Adiponectin levels were associated with increased likelihood of metabolic health improvements and lower risk for diabetes across 6 years.

Clinical outcome of radiofrequency ablation in elderly hepatocellular carcinoma patients over 80 years old. Results from a phase 2 study of triplet blockade of the IL-27, PD-(L)1, and VEGF pathways ...

Can-Fite BioPharma has secured a US patent for Namodenoson, its lead drug candidate, for use as an anti-obesity treatment.

Weekly USDA US beef, pork export sales. Beef: Net US sales of 20,200 MT for 2025 were primarily for South Korea (11,300 MT, ...

Researchers from India examined the effects of Cinnamomum zeylanicum (ceylon cinnamon) bark extracts on adiposity, insulin sensitivity and cardiometabolic markers. Their findings were published in the ...

The Namodenoson oral drug is well positioned in the field of anti-obesity agents due to its activity and favorable safety ...

Key Takeaways Peptides offer a non-invasive, natural approach to promoting hair growth and combating hair loss. They ...

What do you know about the endocrine system? In school, we learned that hormones and the glands that produce them comprise ...

Women with early menopause are likely to have a higher risk of heart failure, reveals a study published in the Menopause.The mechanisms through which menopausal age influences heart failure ...

The US Patent Office has accepted patent application No 17/309,952, titled “An A3 adenosine receptor ligand for use for achieving a fat loss effect,” which is supported by the data showing Namodenoson ...